A B S T R A C T The humana Ial-like aintigens, selectively expressed on B lymphocytes, are noow recognized to be closely associate(l with, or identical to, the genie prodlucts of the imaljor histocompatibility complex responsil)le for stimulation in the mixed lymphocyte reaction. The leuikemie B lymphocytes of patienits wvith chronie lylmphocytic leukemnia express these antigens very well. In the presenit stuidy they were readily dletected by several techniq(uies utilizing 1)oth allo-anid heteroanitiseral. However 
A B S T R A C T The humana Ial-like aintigens, selectively expressed on B lymphocytes, are noow recognized to be closely associate(l with, or identical to, the genie prodlucts of the imaljor histocompatibility complex responsil)le for stimulation in the mixed lymphocyte reaction. The leuikemie B lymphocytes of patienits wvith chronie lylmphocytic leukemnia express these antigens very well. In the presenit stuidy they were readily dletected by several techniq(uies utilizing 1)oth allo-anid heteroanitiseral. However, the leukemiic B cells fromii mlost patienits were founid to be extremiiely poor stimiulatinig cells in the miiixed lymphocyte reaction. This wvas particulatrly apparenit when comiiparisons were mclade on a B-cell basis with isolated normal B lymphocytes.
Leukemic cell death, abnormal kinetics of leukemnic cell-me(liated stimulation, anid serum or cellular suppressor factors do not appear to explain these findings. Studies (8) (9) (10) (11) . Most cases of chronic lymphocytic leukemia (CLL) represent a neoplastic proliferation of B lymphocytes (12) which, like their normal counterparts, express membrane immunoglobulin (Ig) and Ia antigens (2, 3, 13) . Therefore, it was of interest to examine the stimulatory capacity of these cells which can be obtained readily in large a(mounts and in a highly purified state. (14) . The nonpelleting (interfiace cells) contained <2.5% of cells capable of forming E rosettes. This was followed by monocyte depletion using one of three techni(lues: 107 peripheral blood mononuclear (PBM) cells were incubated at 37°C with 40-80 mg of carbonyl iron (superfine, GAF Corp., New York). After 1-h incubation, the iron-laden monocytes were retained by a magnet and the lymphocytes were harvested. Monocytes were also removed by allowing them to adhere to plastic flasks for 1-2 h in RPMI 1640-10% fetal calf serum at 37°C. The third method of monocyte depletion employed humlan erthrocytes sensitized by human anti-Rh allosera. The sensitized cells form rosettes with monocytes and third popuilation cells (15) which can be removed by gradient centrifugation.
METHODS
B cells bearing surface IgM were isolated from T-cell-and monocyte-depleted PBM according to their capacity to form rosettes with purified anti-IgM antibodies covalently linked to bovine erythrocytes by the CrCl3 method.2 Briefly, the cells were rosetted with the anti-IgM bovine erythrocyte reagent for 1 h at 40C followed by two Ficoll-Hypa(lue gradient centrifugations. The pellet obtained was shock-lysed with an (NH4)CI-tris buffer and washed in phosphate-buffered saline before cultuiring.
Cell Characterization. Rhodamine-conjugated F(ab')2 fragments specific for IgM, IgG, IgD, and IgA were prepared and used for surface staininig of lymphocytes as previously described (16) . Ia alloantigens were detected with sera obtainied from multiparous w%omen in an indirect fluorescence assay using F(ab')2 fragments of rabbit anti-humani Ig antisera, as described (1) . Rabbit antisera against pturified human Ia antigens were made as described previously (2) bimolecular complex whose components have mol wt of 28,000 and 37,000 daltons (2) .
T cells were enumerated by rosette formation with neuraminidase-treated E. Fc receptors were detected by immune complex binding (2) and rosette formation between Fcbearing lymphocytes and ox erythrocytes sensitized by rabbit anti-ox erythrocytes, according to Haegert et al. (17) .
Monocytes were enumerated by their appearance in Wrightstained preparations, latex ingestion (2), and by detection of endogenous (18) Experimental designt. In each experiment the MLR responses of PBM from two normal subjects to a leukemic stimulator were measured. In addition, the response of each normal subject to the other normal serving as a stimulator was determined. This experimental design allowed the direct comparison of the abilities of normal and leukemic PBM to stimulate the same responder. Thus, the autologous counts (responder's MLR response to his own irradiated cells) are the same for the simultaneously tested stimulators. Hence, in most cases stimulation indices were not tabulated.
In some experiments two leukemic subjects were tested simultaneously, allowing comparison of their capacities to stimulate the same responders.
Stimulator cells were tested at two-fold dilutions varying from a concentration of 107-3.12 x 10S cells/ml. (Fig. 1 ).
RESULTS

Characterization
There was considerable heterogeneity in the stimulatory capacity of the cells obtained from these 19 leukemnic subjects (Table I) . Thus, at the stimutlator cell concentration at which normal PBNI gave mlaximnal stimulation PBM1 from these leukemic .;subjects gener- 10 Stimulator cell concentration X 1o-6 FIGURE 1 Contrasts in NMLR stimulation generated by normal and leukemiiie PBM. The responses of PBM from one normal subject to varying numbers of PBM from another normal (-), CLL C (A), and CLL G (0) are show.,n. Autologous responder counts were 1,100.
Poor Mixed Lymphocyte Reaction Capacity of Leukemic B Cells 1 143 ated l)etween 5 and 64% of the stimulation generated by the simultaneously tested normal subject. In 45 of the 82 comparisons, the leukemic cells generated <25% of the MLR response generated by the simultaneously tested PBM obtained from normal subjects and in only 15 of the comparisons did the stimullationi genierated by leukemic cells exceed 50% of that geinerate(d by the niormal cells. The variation was also seen at stiiiulator cell concentration of 107 cells/ml. However, at this concentration, because of the contrasts in the dose-response curves, in over half of the comparisoiis the leukemic cells generated mnore stimulation than did the normial PBM, whereas in only 29 comparisons didl they generate <50%. There was no clear relation l)etween stinmulatory capacity of the leukemias and cell count, percent of cells forming E rosettes, percent of monocytes or presence or absence of readily detectable surface memnbrane Ig on the leukemic B cells (Table I) .
The two leukemic patients whose cells generated a dose-responise cuirve similar to those generated by the simnultaneously tested normals wvere patienits Ei (Fig.  2) anid S.e, whose leukemic B cells have been shown to be capable of differentiation both in vivo an-d in vitro (20) . Similar results were obtained when patient Ei was retested on multiple occasions, despite an increase in the leukocyte count from 17,000 to 45,000 and a decrease in monocytes from 13 to 3%.
Several factors were excluded as the explanation for the different results obtained with leukemic and normal PBM. Stimulator cell viability, as assessed by trypan blue exclusion, of irradiated cells cultured in the absence of responder cells was >80% after 2 d. After a 6-d cultture, viability ranged from 40 to 60% but was no different for leukemic and normlal cells. As leukemic cells gave minimal MLR response, they could be used as stimullators without irradiation. However, omiission of irradiation did not change their stimiulatory capacity. Substitution of plasma from leukemie or niormal subjects for AB serumil did not alter the ressults of the experimenits.
Restults obtained with cell counts acnd blast counts were consistent with those foun(d with [:IH]thymnidine uptake in the three MLR in which they were compared. Although imiost normiial subjects used in these experiments wvere younlger than the leukemic patients, results obtained uisinig four normal subjects over the age of 60 as doniors of the stimulator cells were essentially the saime ats when younger subjects wvere uisedl. These include(d one experimiienit in which the stimulatory capacity of a leuikemiiia subject's cells was compared1 to that of her sister who wdas of similar alge.
The kinetics of the MLR was studied f'or four leUkemic sul)jects. Harvesting of cultures at 3 atnd 8 d significanitly decreased the amouint of stimulniation generatedl by the stimultaneously studied normall subject but faile(d to increase the stimtulationi genierate(1 by the leukemiiic cells.
In severatl of the MLR studied, the normal responder lacked one or more Dr anitigens expressed in the leukemic stimulaltor. Despite these alloantigenic differences, implying D-locus disparities, the leuikemic stimulators generated the typical "leuikemic patterni" of low MLR stimulation. Fig. 3 depicts the contrasting stimulatory capacities of PBM from la leuikemiic subject and her HLA identical sister; the leuikemnic sibling gave a typical leukemic pattern of MLR stimulation, whereas her normal sibling generated a normal pattern of stimulation. The same contrasting reactivity wvas givein by the leukemic sibling's and niormal sibling's cells wheni tested against several normal responders. These findlings were of particular significance because by several lines of evidence, these siblings were MHC identical. These criterial inclu(ded, in addition to HLA inidentity, identical typing by at paniel of Dr aintisera, andi(l lack of Stimulator cell concentration X 10-6 FIGURE 2 MLR stimulatory capacity of PBM from leukemic subject Ei (0) and a normal subject (-). Autologous couints were -800.
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Halper Poor Mixed Lymphocyte Reactiotn Capacity of Leukemic B Cells 1145 rhodamine-conjugated F(ab')2 fragments of anti-Ia heterosera. Percentage of positive cells and intensity of fluorescence at each dilution were scored by an independent observer. The staining properties of the leukemic cells from the two patients were indistinguishable despite their dissimilar MLR stimulatory capacities; both reacted at least as strongly as the normal B cells. The capacity of the above two leukemic B cells to absorb anti-Ia heterosera was also compared to that of purified normal B lymphocytes. Graded numbers of cells from each of the three cell preparations were added to 100 gl of diluted fluorochrome-conjugated F(ab')2 fragments of anti-Ia heterosera in U-bottomed microplates. After 2 h at 4°C the plates were centrifuged and the supernates' ability to stain cells from a B-lymphoblastoid cell line and normal B cells was measured. On the basis of the number of cells re(luired to absorb out fluorescence activity, cells from Ei were 80-100% as efficient as normal B lymphocytes; those from J were 116-140% as efficient as normal B lymphocytes.
Stimulatory capacity of mlixtures of PBM isolated from normnal atnd leukemic subjects. To investigate the possibility that PBM isolated from leukemic patients contained a population capable of inhibiting a normal MLR or lacked an accessory cell required for stimulation, the stimulatory capacities of mixtures of normnal and leukemic cells were examined. In seven such experiments, using cells from different leukemic subjects, the observed values were well within ±33% of those calculated with only occasional exceptions. Thus, there was no evidence of inhibition or reconstitution. The results obtained with a mixture of cells from the leukemic and normal HLA identical siblings are shown in Table II and clearly demonstrate the absence of a suppressor effect of the leukemic population.
In related experiments it was found that depletion of residual T cells from leukemic PBM in two cases did not enhance the stimulatory capacity of the remaining B lymphocytes. Hence, specific MLR suppressor T cells could not be demonstrated in the leukemic population.
DISCUSSION
When used as stimulators in the MLR in the system described above, PBM prepared from normal subjects give increasing stimulation with increasing stimulator concentration until maximal stimulation is reached at 1.25-2.5 x 106 cells/ml (stimulator responder ratio = 1 or 2). As stimulator cell concentration is further increased, stimulation falls off. In conitrast, PBM isolated from most subjects with CLL give relatively low stimulation at the concentrations at which normal PBM generate maximal stimulation, and the stimulation (20) .
Previous studies of the MLR stimulatory capacities of CLL lymphocytes have reported both normal (25) (26) (27) and decreased stimulatory capacity (28, 29) . However, it is apparent in all of the studies that when the data are recalculated on a per B-cell basis, the MLR generated by CLL subjects are abnormal. On PBM isolated from patients with CLL contain a decreased proportion of monocytes, cells which are required, in smiall numbers, to support the MLR (21, 22) . However, normal B cells depleted of monocytes by a variety of techni(lues so that they contained a percentage of moniocytes similar to or lower than that found in the leukemnic PBM1 were excellent stimulators. Monocyte depletion, however, did lead to an attenuation of the decrease in stimulation at high stimulator concentrations seen with normal but not leukemic PBM .
In a recenit study, Steinman and Witmer (24) reported that for mouse spleen the primary stimulatory cells in the MLR is an Ia-positive dendritic cell, and they brought into (luestion a significant role for B cells.
Previous work (8) (9) (10) (11) appearing to demonstrate the strong stimulatory capacity of the B cell in the human MLR did not utilize B cells purified sufficiently to eliminate minor populations of active contaminating cells, such as the dendritic cells. However, the new techni(lue of isolating B cells using anti-IgM-coated erythrocytes allowed isolation of B cells free of contaminating Ia-positive non-B cells. Conclusive evidence for the strong stimulatory capacity of normal B cells was obtained,2 ruling out the B-cell nature of CLL lymphocytes as the explanation for their poor stimulatorv capacity.
Because of the identity of, or close relationship between, Ia antigens and the MHC determinants (LD) responsil)le for stimulation in the MLR, the expression of these antigens by the leukemic cells was examined. These cells wNere found to express Ia antigens as strongly as normal B lymphocytes as assessed by fluoreseent staining and absorption studies. This is consistent with previous results using anti-Ia heterosera and the fluorescence-activated cell sorter (13) . The alloantigenic portions of the Ia molecules were also found to be expressed normally on CLL B cells in other studies (2, 30) , and the bimolecular complexes precipitated from normal and leukemic B cells shown to be identical (30) .
Recently, several diseases have been found to be associated with Ia and/or LD antigens (31) , and this group may include CLL (32) . Results with the MHC identical siblings and the failure of the leukemic cells to stimulate any of the large number of genetically heterogenous normal responders, soime of whom lacked Dr antigens expressed by cells of the leukemic subjects they were tested against, argue against a genetic explanation for the decreased stimulatory capacity of leuikemic cells.
To serve as a stimulator in the MILR, it is likely that a cell must meet certain metabolic and membrane functional re(quirements in addition to possessing the Dlocus antigens (33, 34) . Many abnormalities in these parameters have been documented in CLL (35 
